Evidence map›Paper›PMID 42209803›Full record

ArticleCurrent microbiology2026

Exploring a Pathogenomic Approach and the Galleria mellonella Model to Evaluate the Virulence of Arcobacter butzleri.

Jose Gonzalez-Morales, Sofía Ochoa, Cristian Montalva, Luis Collado

Abstract read
PubMed Publisher
In one paragraph

Article in Current microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jose Gonzalez-MoralesInstituto de Bioquímica y Microbiología, Facultad de Ciencias, Universidad Austral de Chile, Isla Teja Campus, Valdivia, Chile.
Sofía OchoaDepartamento de Ciencias de la Salud, Facultad de Ciencias de la Salud, Universidad Técnica Particular de Loja, Loja, Ecuador.
Cristian MontalvaInstituto de Conservación, Biodiversidad y Territorio, Facultad de Ciencias Forestales y Recursos Naturales, Universidad Austral de Chile, Valdivia, Chile.
Luis ColladoInstituto de Bioquímica y Microbiología, Facultad de Ciencias, Universidad Austral de Chile, Isla Teja Campus, Valdivia, Chile. luiscollado@uach.cl.ORCID http://orcid.org/0000-0002-7140-4219

Funding

Fondo Nacional de Desarrollo Científico y Tecnológico 1200125
6 · The paper itself

Abstract

Arcobacter butzleri is an emerging zoonotic pathogen described in 1991. Despite its increasing incidence in clinical cases, there is still a need to better understand the underlying mechanisms of pathogenicity. Therefore, the aim of this study was to evaluate if different virulence profiles of A. butzleri are associated with different extent of virulence in the Galleria mellonella experimental model. Twenty-one A. butzleri strains isolated from various sources were characterized by searching for putative virulence determinants (PVDs) through genomic analysis and PCR (i.e., cadF, cj1349, ciaB, mviN, tlyA, pldA, irgA, hecA, hecB, and iroE genes). Seven virulence profiles were obtained (designated as Profile A to G). A representative strain from each profile was selected to conduct assays in the G. mellonella model. Even though the profile C was the most virulent, there was no correlation between the virulence profiles and G. mellonella mortality/melanization. Our study show that G. mellonella is a reliable and cost-effective model for studying the pathogenicity of A. butzleri. However, our results underscore the significance of evaluate additional virulence factors beyond the analyzed PVDs.

Indexed as

ArcobacterGram-Negative Bacterial InfectionsMothsVirulence FactorsAnimalsBacterial ProteinsDisease Models, AnimalLarvaVirulenceBacterial ProteinsVirulence Factors

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.